Bipolar Disorder Depression Clinical Trial
Official title:
Vortioxetine add-on Treatment Improves the Symptoms in Patients With Bipolar Depression
The purpose of this study is to validate the efficacy of Vortioxetine augmentation in bipolar disorder patients with depressive symptoms.
In this study, the investigators are going to examine the efficacy of vortioxetine
augmentation in bipolar disorder patients with depressive symptoms.
The study design is a double-blinded 6-week prospective study. It would be useful for
clinicians because it will provide new evidence for the effect of vortioxetine in bipolar
disorder patients with depressive symptoms.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01429272 -
Minocycline and Aspirin in the Treatment of Bipolar Depression
|
Phase 3 | |
| Withdrawn |
NCT04430959 -
Candesartan as an Adjunctive Treatment for Bipolar Depression
|
Early Phase 1 | |
| Recruiting |
NCT04211961 -
Scopolamine in Bipolar Depression
|
Phase 2 | |
| Recruiting |
NCT05608135 -
AI-based Multi-center Research on Identification/Classification/Aided Diagnosis of Mood Disorder
|